Showing results (81-90 of 415) with videos related to

Sort By:
Pageof 42
Breast Cancer Research : BCR|July 1, 2005
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family StudyJiun-Horng Chang, Dorota M Gertig, Xiaoqing Chen, et al.
Oncotarget|February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell linesMajid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Breast Cancer Research and Treatment|June 11, 2008
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Andrew J Deans, David Duffy, et al.
Genes, Chromosomes & Cancer|September 27, 2006
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profilingNic Waddell, Jyoti Jonnalagadda, Anna Marsh, et al.
The Journal of Biological Chemistry|March 24, 2007
A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBPJulia K Pagan, Jeremy Arnold, Kim J Hanchard, et al.
Scientific Reports|May 10, 2014
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancerBo Gao, Amanda Russell, Jonathan Beesley, et al.
International Journal of Cancer|September 25, 2020
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analysesJue-Sheng Ong, Eske M Derks, Mikael Eriksson, et al.
Plos One|March 23, 2011
Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesisCatherine Emmanuel, Natalie Gava, Catherine Kennedy, et al.
Molecular Cancer Research : MCR|November 18, 2008
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumorsMichael S Anglesio, Jeremy M Arnold, Joshy George, et al.
NPJ Breast Cancer|January 21, 2026
CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancerWei Shi, Yi Luo, Yizhuo Wang, et al.
Pageof 42